Mental health conditions now rank among the leading drivers of maternal death in the United States, yet the women at greatest biological risk — those navigating high-risk pregnancies — remain the least studied and least supported in clinical psychiatric frameworks. That gap has measurable consequences: more than one in five pregnancy-related deaths in the U.S. involves a mental health condition, a statistic that reframes perinatal mental illness not as a side concern but as a frontline mortality issue.
This expert review, published in the American Journal of Obstetrics & Gynecology MFM, synthesizes existing literature on perinatal mental health specifically among individuals experiencing pregnancy complications — a population disproportionately affected by depression, anxiety, and post-traumatic stress disorder compared with those experiencing uncomplicated pregnancies. The review identifies critical deficiencies in the research base and proposes a multi-pronged clinical framework: adapting preventive mental health interventions for high-risk obstetric contexts, expanding formal perinatal mental health education during medical training, broadening systematic screening protocols, and deploying collaborative care models to extend psychiatric services through both the prenatal and postpartum periods.
This work arrives at a moment when perinatal psychiatry is maturing as a subspecialty but still struggles with implementation at scale, particularly for medically complex patients whose obstetric appointments are already burdened with physiological monitoring. A key insight embedded in this review is that pregnancy complications themselves — preeclampsia, preterm labor, fetal anomalies — may function as traumatic stressors that precipitate or worsen psychiatric conditions, yet standard mental health screening tools were not designed with this population in mind. The collaborative care model proposed here has the strongest evidence base among the recommendations, having demonstrated efficacy in primary care settings, though robust randomized data specific to high-risk obstetric populations remain sparse. As an expert review rather than a meta-analysis or clinical trial, its conclusions are expert-consensus level, not yet definitive — but the clinical logic is compelling and the mortality data make inaction increasingly difficult to justify.
